Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein

Published:2023-03-01 Issue:5-6 Volume:34 Page:203-216
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Schellhorn Sebastian¹,Brücher Dominik²,Wolff Natascha A.³,Schröer Katrin¹,Sallard Erwan¹,Mese Kemal¹,Zhang Wenli¹,Ehrke-Schulz Eric¹^ORCID,Thévenod Frank³,Plückthun Andreas²,Ehrhardt Anja¹^ORCID

Affiliation:

1. Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany

2. Department of Biochemistry, University of Zurich, Zurich, Switzerland

3. Institute of Physiology, Pathophysiology, and Toxicology, Center for Biomedical Training and Research (ZBAF), Witten/Herdecke University, Witten, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2022.215

Reference47 articles.

1. Cancer statistics for the year 2020: An overview

2. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

3. Current Perspectives in Cancer Immunotherapy

4. Current Trends in Cancer Immunotherapy

5. Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP